Quay Pharma

quaypharma.com

Quay Pharma is experienced in providing a comprehensive out-sourcing service for formulation and analytical development with subsequent clinical trials manufacturing for pharmaceutical and biotechnology companies world-wide.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

news image

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More

Business Insights

EX-BIOCON TEAM SYMBIO GENERRICS COMPLETES CAPITAL RAISE FROM ASCENT CAPITAL

Symbio Generrics | November 25, 2022

news image

Symbio Generrics India Private Limited a specialized Active Pharmaceutical Ingredients & Intermediates manufacturing and marketing organization, announced that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharma...

Read More

NEW AMR ACTION FUND STEPS IN TO SAVE COLLAPSING ANTIBIOTIC PIPELINE WITH PHARMACEUTICAL INDUSTRY INVESTMENT OF US$1 BILLION

AMR Action Fund | July 09, 2020

news image

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resi...

Read More

Pharmacy Market

GLUCARE.HEALTH PARTNERS WITH NOVO NORDISK FOR INNOVATIVE WEIGHT MANAGEMENT PATIENT PROGRAM

Glucare.Health and NovoNordisk: | June 09, 2022

news image

GluCare.Health, one of the Middle East's leading health tech startups, has partnered with global pharmaceutical company Novo Nordisk, market leader in Diabetes & Obesity, to introduce a blueprint for the future of healthcare. The partnership will see a 150-patient weight management pilot program that will combine new digital bio-markers, using wearable technology and devices for continuous data monitoring, with existing therapeutics. It introduces the Middle East's fir...

Read More
news image

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More
news image

Business Insights

EX-BIOCON TEAM SYMBIO GENERRICS COMPLETES CAPITAL RAISE FROM ASCENT CAPITAL

Symbio Generrics | November 25, 2022

Symbio Generrics India Private Limited a specialized Active Pharmaceutical Ingredients & Intermediates manufacturing and marketing organization, announced that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharma...

Read More
news image

NEW AMR ACTION FUND STEPS IN TO SAVE COLLAPSING ANTIBIOTIC PIPELINE WITH PHARMACEUTICAL INDUSTRY INVESTMENT OF US$1 BILLION

AMR Action Fund | July 09, 2020

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resi...

Read More
news image

Pharmacy Market

GLUCARE.HEALTH PARTNERS WITH NOVO NORDISK FOR INNOVATIVE WEIGHT MANAGEMENT PATIENT PROGRAM

Glucare.Health and NovoNordisk: | June 09, 2022

GluCare.Health, one of the Middle East's leading health tech startups, has partnered with global pharmaceutical company Novo Nordisk, market leader in Diabetes & Obesity, to introduce a blueprint for the future of healthcare. The partnership will see a 150-patient weight management pilot program that will combine new digital bio-markers, using wearable technology and devices for continuous data monitoring, with existing therapeutics. It introduces the Middle East's fir...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us